StreetInsider.com News Articles

Form 4 BOSTON SCIENTIFIC CORP For: Aug 10 Filed by: Monson Jonathan

Tue, 11 Aug 2026 16:40:00 -0400

si-local-file:///var/storage/secattach/20260811/26906511.html

Form 4 BOSTON SCIENTIFIC CORP For: Aug 10 Filed by: Monson Jonathan

Tue, 11 Aug 2026 16:40:00 -0400

si-local-file:///var/storage/secattach/20260811/26906511.html

Boston Scientific announces participation in Wells Fargo 21st Annual Healthcare Conference and conference call discussing third quarter 2026 results

Mon, 10 Aug 2026 08:00:00 -0400

MARLBOROUGH, Mass., Aug. 10, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in Wells Fargo's 21^st Annual Healthcare Conference on Thursday, September 10, 2026. Mike Mahoney, chairman and chief executive officer, and Kenneth Stein, M.D., senior vice president and global chief medical officer, will participate in a 35-minute question-and-answer session with the host analyst at approximately 8:00 a.m. ET.

Boston Scientific announces participation in Wells Fargo 21st Annual Healthcare Conference and conference call discussing third quarter 2026 results

Mon, 10 Aug 2026 08:00:00 -0400

Boston Scientific announces participation in Wells Fargo 21st Annual Healthcare Conference and conference call discussing third quarter 2026 results

Mon, 10 Aug 2026 08:00:00 -0400

Boston Scientific announces participation in Wells Fargo 21st Annual Healthcare Conference and conference call discussing third quarter 2026 results

Mon, 10 Aug 2026 08:00:00 -0400

Form 4 BOSTON SCIENTIFIC CORP For: Aug 05 Filed by: Habiger David C

Fri, 07 Aug 2026 16:16:00 -0400

si-local-file:///var/storage/secattach/20260807/26891274.html

Form 4 BOSTON SCIENTIFIC CORP For: Aug 05 Filed by: Habiger David C

Fri, 07 Aug 2026 16:16:00 -0400

si-local-file:///var/storage/secattach/20260807/26891274.html

Form SCHEDULE 13G/A BOSTON SCIENTIFIC CORP Filed by: FMR LLC

Thu, 06 Aug 2026 10:18:00 -0400

si-local-file:///var/storage/secattach/20260806/26881076.html

Form SCHEDULE 13G/A BOSTON SCIENTIFIC CORP Filed by: FMR LLC

Thu, 06 Aug 2026 10:18:00 -0400

si-local-file:///var/storage/secattach/20260806/26881076.html

Form 4 BOSTON SCIENTIFIC CORP For: Aug 03 Filed by: Mahoney Michael F

Wed, 05 Aug 2026 16:16:00 -0400

si-local-file:///var/storage/secattach/20260805/26874569.html

Form 4 BOSTON SCIENTIFIC CORP For: Aug 03 Filed by: Mahoney Michael F

Wed, 05 Aug 2026 16:16:00 -0400

si-local-file:///var/storage/secattach/20260805/26874569.html

Form 4 BOSTON SCIENTIFIC CORP For: Aug 03 Filed by: Habiger David C

Wed, 05 Aug 2026 16:16:00 -0400

si-local-file:///var/storage/secattach/20260805/26874575.html

Form 4 BOSTON SCIENTIFIC CORP For: Aug 03 Filed by: Habiger David C

Wed, 05 Aug 2026 16:16:00 -0400

si-local-file:///var/storage/secattach/20260805/26874575.html

Form 4 BOSTON SCIENTIFIC CORP For: Jul 31 Filed by: LUDWIG EDWARD J

Mon, 03 Aug 2026 16:30:00 -0400

si-local-file:///var/storage/secattach/20260803/26858480.html

Form 4 BOSTON SCIENTIFIC CORP For: Jul 31 Filed by: LUDWIG EDWARD J

Mon, 03 Aug 2026 16:30:00 -0400

si-local-file:///var/storage/secattach/20260803/26858480.html

Form 4 BOSTON SCIENTIFIC CORP For: Jul 31 Filed by: Fitzgerald Joseph Michael

Mon, 03 Aug 2026 16:30:00 -0400

si-local-file:///var/storage/secattach/20260803/26858481.html

Form 4 BOSTON SCIENTIFIC CORP For: Jul 31 Filed by: Fitzgerald Joseph Michael

Mon, 03 Aug 2026 16:30:00 -0400

si-local-file:///var/storage/secattach/20260803/26858481.html

Form 10-Q BOSTON SCIENTIFIC CORP For: Jun 30

Mon, 03 Aug 2026 06:32:00 -0400

si-local-file:///var/storage/secattach/20260803/26853449.html

Form 10-Q BOSTON SCIENTIFIC CORP For: Jun 30

Mon, 03 Aug 2026 06:32:00 -0400

si-local-file:///var/storage/secattach/20260803/26853449.html

Argus Downgrades Boston Scientific (BSX) to Hold

Fri, 31 Jul 2026 07:26:42 -0400

(Updated - July 31, 2026 7:26 AM EDT)

Argus analyst David Toung downgraded Boston Scientific (NYSE: BSX) from Buy to Hold.

The analyst comments "• Downgrading to HOLD from BUY. • Boston Scientific faces headwinds to growth in key product platforms, including WATCHMAN, electrophysiology, and urology. • WATCHMAN and Electrophysiology products were high-growth areas in 2025, but are facing declines in the second half of 2026. • BSX cut guidance for the second quarter in a row, clouding visibility about a return to growth."

For an analyst ratings summary and ratings history on Boston Scientific click here. For more ratings news on

Argus Downgrades Boston Scientific (BSX) to Hold

Fri, 31 Jul 2026 07:26:42 -0400

(Updated - July 31, 2026 7:26 AM EDT)

Argus analyst David Toung downgraded Boston Scientific (NYSE: BSX) from Buy to Hold.

For an analyst ratings summary and ratings history on Boston Scientific click here. For more ratings news on

Penumbra, Inc. Reports Second Quarter 2026 Financial Results

Thu, 30 Jul 2026 16:05:00 -0400

ALAMEDA, Calif., July 30, 2026 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, today reported financial results for the second quarter ended June 30, 2026.

Penumbra, Inc. Reports Second Quarter 2026 Financial Results

Thu, 30 Jul 2026 16:05:00 -0400

ALAMEDA, Calif., July 30, 2026 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, today reported financial results for the second quarter ended June 30, 2026.

Penumbra, Inc. Reports Second Quarter 2026 Financial Results

Thu, 30 Jul 2026 16:05:00 -0400

ALAMEDA, Calif., July 30, 2026 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, today reported financial results for the second quarter ended June 30, 2026.